期刊文献+

小鼠beta-防御素2真核表达载体的构建及表达 被引量:1

Molecular Cloning and Expression of Murie beta-Defensin 2 in Siha Cell
下载PDF
导出
摘要 构建小鼠beta-防御素2(murie beta-defensin 2,mBD2)的真核表达载体pcDNA-mBD2,并观察其在真核细胞中的表达。从小鼠肝组织中提取mRNA通过逆转录聚合酶链反应扩增得到mBD2基因,定向克隆至真核表达载体pcDNA3.1(+)获得pcDNA-mBD2;经酶切和测序鉴定构建正确,应用脂质体法转染siha细胞,并通过蛋白免疫印迹法检测细胞内mBD2的表达。结果显示,构建了小鼠mBD2的真核表达载体,转染siha细胞培养并采用G418稳定筛选后,获得稳定转染细胞,收集并裂解转染细胞,蛋白免疫印迹法检测到转染细胞内mBD2的表达。成功构建了真核表达载体pcDNA-mBD2,为研究mBD2在宫颈癌发生发展过程中的作用及作用机制奠定基础。 The research was to construct a recombinant eukaryotic expression vector.Total RNA was extracted from mouse liver tissue,and reverse transcription polymerase chain reaction(RT-PCR),then the murie beta-defensin 2(mBD2)DNA was inserted into the pcDNA3.1(+)vector by EcoR I and Xho I cloning sites.The construct of pcDNA/mBD2 was further conformed by restricted enzyme digestion analysis and DNA sequencing.The expression of mBD2 was detected by Western blotting assay.Results showed that the eukaryotic expression vector pcDNA-mBD2 was constructed correctly,and significant expression was detected in siha cells aftert ransfection constantly.This result would facilitate the future study on the f unction and mechanism of mBD2 in uterine cervix cancer.
出处 《生物技术通报》 CAS CSCD 北大核心 2011年第5期98-101,共4页 Biotechnology Bulletin
基金 自治区高校科研计划项目(XIEDU2009I20) 新疆包虫病基础医学重点实验室开放课题(XJDXO0202-2008-04)
关键词 beta-防御素2 真核表达 逆转录聚合酶链反应 蛋白免疫印迹 beta-defensin 2 Eukaryotic expression RT-PCR Western blotting assay
  • 相关文献

参考文献10

  • 1Krug LM, Grant SC, Miller VA, et al. Strategies to eradicate mini- mal residual disease in cell lung cancer: high-dose chemotherapy with autologous bone marrow transplantation, matrix metalloprotein- ase inhibitors, and BEC2 plus BCG vaccination. Semin Oncol, 1999,26(5 suppl. 15) :55-61.
  • 2Magliani W, Conti S, Cunha RL, et al. Antibodies ascrypts of anti- infective and antitumor peptides. Curr Med Chem, 2009,16 ( 18 ) : 2305-2323.
  • 3Alipour M, Halwani M, Omri A, et al. Anti microbial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains. Int J Pharm, 2008,355 ( 1-2 ) :293-298.
  • 4Smyth M J, Crowe NY, Hayakawa Y, et al. NTK cells--conductions of tumor immunity. Current Opinion in Immunology, 2002,14 (2) : 165-171.
  • 5St George JA. Gene therapy progress and prospects: adenoviral vec- tors. Gene Ther,2003,10:1135-1141.
  • 6Hompson JA, Figlin RA, Sifri-Steelc C, et al. A phase I trial of CD3/CD28-activated T cells( Xcellerated T cells) and interleukin-2 in patients with metastatic renal cell carcinoma. Clin Cancer Res, 2003,9(10) :3562-3570.
  • 7Ugai S, Shimozato O, Yu L, et al. Transduction of the IL-21 and IL- 23 genes in human pancreatic ceils produces natural killer cell-de- pendent and -independent antitumor effects. Cancer Gene Ther, 2003,10:771-778.
  • 8Shen Y, White E. p53-dependent apoptosis pathways. Adv Cancer Res,2001,82:55-84.
  • 9Opalka B, Dickopp A, Kirch HC. Apoptotic genes in cancer thera- py. Cell Tissues Organs, 2002,172 ( 2 ) : 126-132.
  • 10McNeish IA, Bell SJ, Lemoine NR. Gene therapy progress and prospects: cancer gene therapy using tumour suppressor genes. Gene Ther,2004, 11 ( 6 ) :497-503.

同被引文献15

  • 1Ganz T, Selsted ME, Lehrer RI. Defensins. Europe Haemato, 1990, 44(1):1-8.
  • 2Edith M, Tomas G, Robert L. Antibacterial peptide sand other endo- genous peptide antibiotics of vertebrates. Leukocyte Biology, 1995, 58 ( 5 ) : 128-139.
  • 3Ganz T, Selsted ME, Szklarek D, et al. Defensins. Natural peptide antibiotics of human neutrophils. Clin Invest, 1985, 76 ( 4 ) : 1427- 1435.
  • 4Ahn HS, Cho W, Kang SH, et al. Design and synthesis of novel antimicrobial peptides on the basis of a helical domain of Tenecin 1, an insect defensin protein, and structure-activity relationship study. Peptides, 2006, 27 ( 4 ) : 640-648.
  • 5Goldman MJ. Human beta defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell, 1997, 88 ( 4 ) : 553- 560.
  • 6Giacometi A, Cirioni O, Delprete MS, et al. Combination studies between polycationic peptide and clinically used anti-biotics against Gram-positive and Gram-negative bacteria. Peptides, 2000, 21 ( 8 ): 1155-1160.
  • 7Ganz T. Defensins : antimicrobial peptides of innate immunity. Nat Rev Immungl, 2003, 3 ( 9 ) : 710-720.
  • 8Zanetti M. Cathelieidins, muhifunctional peptides of the innate immunity. Leukoc Biol, 2004, 75 ( 1 ) : 39-48.
  • 9Yang D, Biragyan A, Hoover DM, et al. Multiple roles of anti mic- robial defensins, cathelicidins, and eosinophil derived neurotoxin in host defense. Annu Rev Immunol, 2004, 22 : 181-215.
  • 10Nizet V, Ohtake T, Lauth X, et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature, 2002, 414 ( 6862 ) : 454-457.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部